📌 Key Takeaways
- Topic: Amorphous vs Crystalline Silica: Structure, Safety and Uses Compared
- Keywords: quartz powder
- Published: 2026-11-20 12:41:27
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Silica and Hydrofluoric Acid Reaction: Equation, Mechanism and Uses
- Fused Silica vs Quartz: Differences in Structure, Purity and Applications
- This equation fits especially well for premature release, up to 60% of the drug released, when there is no change in the matrix system during the release process. From a perspective of pore geometry, it basically controls drug release rates by affecting effective diffusion pathways. Boosted complexity of geometries raises tortuosity and reduces effective diffusion. High tortuosity and low pore connectivity cut down drug diffusion, consequently lowering the release rates. Furthermore, surface roughness and pore size distribution affect surface region, diffusion, and residence times, and thereby drug release kinetics. Thus, coupling the Fick diffusion model with parameters characterizing pore geometry (e.g., porosity, tortuosity, etc.) enables for more precise and automatic modeling of drug release kinetics. In this way, it is nicely clarified why release profiles differ for chemically comparable matrices due to differences in their geometrical shapes [ 59, 60 ].
- Silica Mesh Size Chart: Mesh to Micron Conversion and How to Choose
- One of the biggest challenges of tableting greatly potent APIs (antibiotics, hormones, cytostatic molecules) is to attain content uniformity [ 95, 96 ]. Since these molecules are used in small doses, it is demanding to attain a homogeneous powder mixture during mixing and to make sure this homogeneity until the end of tableting. Also, it is a hurdle to develop a reproducible method that ensures content uniformity for each production batch, since the specified dose must be made sure between batches, not just within one batch [ 95, 96 ]. A reliable alternative method is to use mesoporous silica as a carrier system rather than simple powder mixing, thus preventing the segregation and aggregation of the low-dose API during mixing and compression. In this case, the preloaded mesoporous carrier and the necessary excipients are mixed, and then the powder mixture can be compressed directly or after granulation. The drug loading can be controlled by the concentration of the drug solution used to fill the carrier systems, which affects the amount of the drug content in the concluding medicine [ 95, 96 ]. Based on this, nearly unlimitedly low doses can be formulated into tablets, even in a concentration of 0.01%, just by properly preparing the solution [ 96 ]. The technique is well-controllable and dependable, since each tablet has the same drug content and the desired content uniformity. Furthermore, the method can be used in both batch-based and continuous production [ 96 ]. This may be a promising finding because there is evidence that it is challenging to move from batch-based to continuous manufacturing while maintaining the desired drug content and content uniformity [ 94 ]. But it should be noted that in this study, no nanocarrier system was used [ 94 ], so utilizing MSN formulations could make an enormous improvement in developing continuous tablet manufacturing [ 96 ]. A study shown that MSN carriers can also be used in orodispersible films to enhance the dissolution of poorly water-soluble drugs [ 100 ]. Based on in vitro drug release studies, more than 90% of prednisolone was released within 2 min when the loaded MSN was incorporated into the formulation. This means a much faster, immediate release in comparison with formulations containing the free form of the drug. In addition, precise dosing can be accomplished utilizing nanocarriers for personalized medication; furthermore, enabling the production of low-dose preparations without content uniformity problems [ 100 ].
- Matting Agent for Coatings: Types, Selection Guide and Performance Comparison
- What Is Tridymite? Structure, Formation and Properties of This Silica Polymorph
- 36. Baumgartner A., Planinšek O. Application of commercially available mesoporous silica for drug dissolution enhancement in oral drug delivery. Eur. J. Pharm. Sci. 2021;167:106015. doi: 10.1016/j.ejps.2021.106015. [ DOI ] [ PubMed ] [ Google Scholar ]
Silica Supplier Middle East: Sourcing Options, Logistics and Key Markets
What is silica (SiO₂)?
microsilica for cement
What is the difference between fumed silica and precipitated silica?
silica powder Malaysia
What drives silica raw material prices?
rheology modifier silica
Cite this article: Silica Raw Materials News. "Silica Reinforcing Filler: How It Strengthens Rubber and Polymers
." Published 2026-11-20 12:41:27.
Disclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.